# US 2021/0228735 A1 · Hydrogel compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0228735 A1
- Document ID: US20210228735A1
- Status: Published application
- Kind: A1
- Application number: 17/055,782
- Filed: 2019-05-17
- Published: 2021-07-29
- Earliest claimed: 2018-05-17
- Assignees: University of Bradford; The University of Sheffield; Hyderabad Eye Institute
- Applicants: L V Prasad Eye Institute; University of Bradford; University of Sheffield
- Inventors: Prashant Garg; Stephen Rimmer; Charles William Ian Douglas
- Web page: https://patentgrep.com/patent/US20210228735A1

## CPC

- A61K 47/6903: {the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 31/785: Polymers containing nitrogen
- A61K 38/12: Cyclic peptides {, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C (A61K38/043 - A61K38/046 take precedence)}
- A61K 38/14: Peptides containing saccharide radicals; Derivatives thereof {, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin}
- A61K 47/58: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61P 31/10: Antimycotics
- C12Q 1/04: Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention relates to hydrogel compositions comprising polymer conjugates capable of selectively binding to fungi, Gram positive bacteria and/or Gram negative bacteria. The hydrogel compositions can be used for detecting the presence of fungi, Gram positive bacteria and/or Gram negative bacteria in a sample.

## Claims

### Claim 1

A hydrogel composition comprising a hydrogel polymeric matrix and a first polymer conjugate, or a salt thereof, having the general formula:
P-[Q]x
wherein:
P is a branched temperature-responsive polymer comprising a plurality of functional groups, and wherein one or more of said functional groups are covalently attached to a ligand capable of binding to ergosterol;
Q is a ligand capable of binding to ergosterol; and
x is the percentage of functional groups on the branched temperature-responsive polymer, P, that are attached to Q, wherein x is greater than or equal to 10%;
together with:
(i) a second polymer conjugate, or a salt thereof, having the general formula:
P1-[Q1]y
wherein:
P1 is a branched temperature-responsive polymer, comprising a plurality of functional groups, and wherein one or more of said functional groups are covalently attached to a ligand capable of binding to Gram positive bacteria;
Q1 is a ligand capable of binding to Gram positive bacteria; and
y is the percentage of functional groups on the branched temperature-responsive polymer, P1, that are attached to Q1, wherein y is greater than or equal to 10%;
and/or
(ii) a third polymer conjugate, or a salt thereof, having the general formula:
P2-[Q2]z
wherein:
P2 is a branched temperature-responsive polymer, comprising a plurality of functional groups, and wherein one or more of said functional groups are covalently attached to a ligand capable of binding to Gram negative bacteria;
Q2 is a ligand capable of binding to Gram negative bacteria; and
z is the percentage of functional groups on the branched temperature-responsive polymer, P2, that are attached to Q2, wherein z is greater than or equal to 10%.

### Claim 2 (depends on 1)

A hydrogel composition according to claim 1, wherein the hydrogel composition comprises a first polymer conjugate of the formula P-[Q]x and either a second polymer conjugate of the formula P1-[Q1]y or a third polymer conjugate of the formula P2-[Q2]z or a salt thereof.

### Claim 3 (depends on 1)

A hydrogel composition according to claim 1, wherein the hydrogel composition comprises a first polymer conjugate of the formula P-[Q]x a second polymer conjugate of the formula P1-[Q1]y and a third polymer conjugate of the formula P2-[Q2]z or a salt thereof.

### Claim 4

A hydrogel composition according to any one of the preceding claims, wherein Q is an antifungal agent capable of binding to ergosterol.

### Claim 5

A hydrogel composition according to any one of the preceding claims, wherein Q is amphotericin B.

### Claim 6

A hydrogel composition according to any one of the preceding claims, wherein x is greater than or equal to 50%.

### Claim 7

A hydrogel composition according to any one of the preceding claims, wherein x is greater than or equal to 80%.

### Claim 8

A hydrogel composition according to any one of the preceding claims, wherein Q1 is an antibacterial agent capable of binding to Gram positive bacteria.

### Claim 9

A hydrogel composition according to any one of the preceding claims, wherein Q1 is vancomycin or a derivative thereof.

### Claim 10

A hydrogel composition according to any one of the preceding claims, wherein y is greater than or equal to 50%.

### Claim 11

A hydrogel composition according to any one of the preceding claims, wherein y is greater than or equal to 80%.

### Claim 12

A hydrogel composition according to any one of the preceding claims, wherein Q2 is an antibacterial agent capable of binding to Gram negative bacteria.

### Claim 13

A hydrogel composition according to any one of the preceding claims, wherein Q2 is polymyxin B or a related derivative capable of binding to lipopolysaccharide.

### Claim 14

A hydrogel composition according to any one of the preceding claims, wherein z is greater than or equal to 50%.

### Claim 15

A hydrogel composition according to any one of the preceding claims, wherein z is greater than or equal to 80%

### Claim 16

A hydrogel composition according to any one of the preceding claims, wherein each Q, Q1 or Q2 group present is bound to a terminus of one of the branches of the polymer P, P1 or P2 respectively.

### Claim 17

A hydrogel composition according to any one of the preceding claims, wherein each Q, Q1 or Q2 group present is bound to a terminus of one of the branches of the polymer P, P1 or P2 respectively by the reaction of a terminal functional group present on P, P1 or P2 with a functional group present on Q, Q1 or Q2 respectively to form a —NR1, —O—, —C(O)—O—, —O—C(O)—, —C(O)—NR1—, —NR1—C(O)—, —S—, —S(O)—, —S(O)2—, —S(O)2—NR1—, —NR1—S(O)2—, —N(H)C(O)O— or a triazole linking group, wherein R1 is hydrogen or (1-4C)alkyl.

### Claim 18

A hydrogel composition according to any one of the preceding claims, wherein each Q, Q1 or Q2 group present is bound to a terminus of one of the branches of the polymer P, P1 or P2 respectively by the reaction of a terminal carboxy group present on P, P1 or P2 with an amine group present on Q, Q1 or Q2 to form a —C(O)—NH— linking group.

### Claim 19

A hydrogel composition according to any one of the preceding claims, wherein P, P1 or P2 is a branched temperature-responsive homopolymer, co-polymer or graft co-polymer.

### Claim 20

A hydrogel composition according to any one of the preceding claims, wherein P, P1 or P2 is a temperature-responsive polymer having branches occurring at every 3 to 30 monomer units.

### Claim 21

A hydrogel composition according to any one of the preceding claims, wherein P, P1 or P2 is a temperature-responsive polymer having branches occurring at every 10 to 25 monomer units.

### Claim 22

A hydrogel composition according to any one of the preceding claims, wherein each of P, P1 or P2 is branched temperature-responsive polymer formed from the polymerisation of: A) temperature-responsive monomers selected from the group consisting of N-substituted alkyl acrylamides and N-substituted alkyl methacrylamides (such as, for example, N-isopropylacrylamide and N-isopropylmethacrylamide), N,N-di-substituted alkyl acrylamide and N,N-di-substituted alkyl methacrylamides (such as, for example, N,N-isopropylacrylamide and N,N-isopropylmethacrylamide), methyl vinyl ethers, vinyl caprolactam, PEG acrylates, and amino acids (that form temperature-responsive peptides) or mixtures thereof; and B) optionally, one or more branching agents.

### Claim 23

A hydrogel composition according to any one of the preceding claims, wherein P, P1 or P2 is a branched temperature-responsive polymer formed from the polymerisation of: A) temperature-responsive monomers selected from the group consisting of N-alkyl substituted acrylamides and N-alkyl substituted methacrylamides (such as, for example, N-isopropylacrylamide and N-isopropylmethacrylamide), N,N-di-alkyl substituted acrylamides and N,N-di-alkyl substituted methacrylamides (such as, for example, N,N-isopropylacrylamide and N,N-isopropylmethacrylamide), methyl vinyl ether, vinyl caprolactam, PEG acrylates or mixtures thereof; and B) optionally, one or more branching agents.

### Claim 24

A hydrogel composition according to any one of the preceding claims, wherein P, P1 or P2 is temperature-responsive polymer formed from: A) monomers selected from the group consisting of N-isopropylacrylamide, N-isopropylmethacrylamide, methyl vinyl ether, vinyl caprolactam, PEG acrylates or a mixture thereof: and B) optionally, one or more branching agents.

### Claim 25

A hydrogel composition according to any one of the preceding claims, wherein P, P1 or P2 is temperature-responsive polymer formed from: A) N-isopropylacrylamide (i.e. the polymer is poly(N-isopropylacrylamide)); and B) one or more branching agents.

### Claim 26 (depends on 22, 23, 24, 25)

A hydrogel composition according to any one of claims 22 to 25, wherein the branching agent is selected from 4-vinylbenzyl-pyrrolecarbodithioate (VPC), vinylbenzyl-phenylcarbodithioate, vinylbenzyl imidazoledithioate, vinylbenzyl alkyldithoates or derivatives thereof.

### Claim 27 (depends on 22, 23, 24, 25, 26)

A hydrogel composition according to any one of claims 22 to 26, wherein the branching agent is 4-vinylbenzyl-pyrrolecarbodithioate (VPC).

### Claim 28 (depends on 22, 23)

A hydrogel composition according to any one of claim 22 or 23, wherein the alkyl groups may comprise 1 to 20 carbons, e.g. 1 to 16 carbons atoms or 1 to 10 carbon atoms.

### Claim 29

A hydrogel composition according to any one of the preceding claims, wherein P is branched poly(N-isopropylacrylamide) and Q is amphotericin B.

### Claim 30

A hydrogel composition according to any one of the preceding claims, wherein the first polymer conjugate P-[Q]x has the formula:
wherein the group in the square brackets is amphotericin B and P and x are each as defined in any one of the preceding claims.

### Claim 31 (depends on 30)

A hydrogel composition according to claim 30, wherein P is branched poly(N-isopropylacrylamide) and each amphotericin B molecule is bound to a terminus of the branched poly(N-isopropylacrylamide) molecule.

### Claim 32

A hydrogel composition according to any one of the preceding claims, wherein P1 is branched poly(N-isopropylacrylamide) and Q1 is vancomycin.

### Claim 33

A hydrogel composition according to any one of the preceding claims, wherein P2 is branched poly(N-isopropylacrylamide) and Q2 is polymyxin B.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

A hydrogel composition according to any one of claims 1 to 33, wherein the polymer conjugates present are bound to the hydrogel polymeric matrix.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

A hydrogel composition according to any one of claims 1 to 34, wherein the polymer conjugates present are covalently bound to the hydrogel polymeric matrix.

### Claim 36

A hydrogel composition according to any one of the preceding claims, wherein the water content of the hydrogel is greater than 50% w/w.

### Claim 37 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

A hydrogel composition according to any one of claims 26 to 36, wherein the water content of the hydrogel is greater than 70% w/w, or greater than 90% w/w.

### Claim 38

A contact lens, membrane, swab or wound dressing comprising a hydrogel composition according to any one of the preceding claims.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A method of detecting the presence of fungal cells, Gram positive bacterial cells and/or Gram negative bacterial cells in a sample, the method comprising:
(i) contacting a hydrogel composition according to any one of claims 1 to 37, or a contact lens, membrane, swab or wound dressing according to claim 38 with the sample;
(ii) removing either the hydrogel composition, contact lens, membrane, swab or wound dressing from the sample and testing for the presence of bound fungal cells, Gram positive bacterial cells and/or Gram negative bacterial cells.

### Claim 40 (depends on 39)

The method of claim 39, wherein presence of fungal cells, Gram positive bacterial cells and/or Gram negative bacterial cells attached to the polymer conjugates present in the hydrogel composition is detected by microscopy/histological assessment, staining and microscopy (e.g. fluorescent microscopy) techniques, or physically removing bound cells and culturing them.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

A method of determining the presence of a fungal, Gram positive bacterial and/or Gram negative bacterial infection and/or diagnosing a fungal, Gram positive bacterial and/or Gram negative bacterial infection, the method comprising:
(i) contacting a hydrogel composition according to any one of claims 1 to 37, or a contact lens, membrane, swab or wound dressing according to claim 38 with either a sample obtained from the suspected site of infection or with the suspected site of infection directly; and
(ii) detecting the presence of any a fungal, Gram positive bacterial and/or Gram negative bacterial cells attached to the hydrogel composition, contact lens, membrane, swab or wound dressing and optionally determining the type of fungi, Gram positive bacteria and/or Gram negative bacteria detected.

### Claim 42 (depends on 41)

The method of claim 41, wherein presence of fungi, Gram positive bacteria and/or Gram negative bacteria is detected by microscopy/histological assessment, staining and microscopy (e.g. fluorescent microscopy) techniques, or physically removing bound cells and culturing them.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The use of a hydrogel composition according to any one of claims 1 to 37, or a contact lens, membrane, swab or wound dressing according to claim 38 for detecting the presence of Gram positive bacteria and/or Gram negative bacteria in a sample or at the site of an infection on the human or animal body.

### Claim 44 (depends on 43)

The use according to claim 43, wherein the hydrogel composition, contact lens, membrane, swab or wound dressing is contacted with the sample in vivo or ex vivo.
